Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2007-10-16 Investor Presentation
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Presentation to Wilson HTM Life Sciences Conference 19 pages ?Kb
Investor Presentation Classification · 95% confidence The document is a detailed presentation from October 2007 focusing on the company's technology, market opportunity, commercialization strategy, and competitive advantages. It contains no financial statements, regulatory disclosures, or voting results. The content is educational and strategic, aimed at informing investors or stakeholders about the company's business and market potential. The length is substantial (15,000 characters), and the style is consistent with an investor presentation rather than a formal report or announcement. There are no indications of it being an annual report, earnings release, or regulatory filing. Therefore, the document best fits the category of an Investor Presentation (IP).
2007-10-16 English
OCL: Nanosonics selects Objective 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 16 October 2007 regarding Nanosonics selecting Objective Corporation's enterprise content management solution. It describes the product and its compliance benefits but does not contain any financial data, regulatory filings, or report publications. The document is a corporate announcement about a business decision or partnership rather than a financial report, management change, or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2007-10-15 English
ADDITIONAL AUSINDUSTRY FUNDING 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 19 September 2007 from Nanosonics Limited to the Australian Securities Exchange. It announces the receipt of additional grant funding from AusIndustry for the development of a medical device. The content focuses on the grant amount, the purpose of the funding, and the stage of product development. There are no financial statements, detailed financial results, or regulatory filings. The document is under 5,000 characters and serves as an update on financing activity related to government grants, which is a form of capital funding. Therefore, it fits best under Capital/Financing Update (CAP).
2007-09-18 English
Audited 2007 Final Report Announcement and Appendix 4E 5 pages ?Kb
Annual Report Classification · 95% confidence The document is titled '2007 Annual Report and 4E Statement' and includes detailed financial data for the year ended 30 June 2007, such as income statements, balance sheets, cash flow statements, and notes to the financial statements. It also references the audited 2007 Annual Report accompanying the announcement and includes a Directors' resolution. The document contains substantive financial data and analysis, not just an announcement or certification. The presence of the Appendix 4E statement, which is a regulatory requirement in Australia for annual reporting, further supports this classification. Therefore, this document is the full Annual Report for the fiscal year ending 30 June 2007. FY 2007
2007-08-22 English
2007 Annual Report 64 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'annual report 2007' and contains detailed sections typical of an annual report, including Chairman's letter, review of operations, corporate governance statement, auditor's independence declaration, directors' report, and financial report with income statements, balance sheets, cash flow statements, and notes to the financial statements. It also includes detailed descriptions of the company's technology, commercialisation strategy, achievements, market development, and R&D activities. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of the report or a certification letter. Therefore, this document fits the definition of an Annual Report (10-K). FY 2007
2007-08-22 English
Commercial developments in Europe and other announcements 8 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement from Nanosonics Limited dated 13 August 2007, addressed to the Australian Securities Exchange. It includes multiple topics: commercial developments in Europe, issuance of new shares following the exercise of options, and a change to the company secretary. The document also contains an ASX Appendix 3B form, which is a standard form used in Australia to announce new issues of securities and apply for quotation of additional securities on the ASX. The content focuses on the issuance of shares and related corporate changes rather than financial results, management discussion, or detailed financial statements. The document is about capital raising activities and share issuance, not a full financial report or earnings release. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (over 13,000 characters) and detailed content support this classification with high confidence.
2007-08-12 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.